Rev Esp Quimioter 2023; 36(6): 655-657
Association of nirmatrelvir/ritonavir and remdesivir as treatment for SARS-CoV-2 infection in immunocompromised patients with hematologic malignancies. Series of four cases
ANA SEGURA FÁBREGA, IGNACIO PÉREZ CATALÁN, IRIS GÓMEZ ALFARO, SERGIO GARCÍA MUÑOZ, CELIA ROIG MARTÍ, NOELIA RODRÍGUEZ LOZANO, SOFÍA FOLGADO ESCUDERO, MARÍA VAREA VILLANUEVA, ADRIANA GASCÓN BUJ, MIGUEL TORRES GARCÍA, ROBERTO REIG VALERO, RAÚL FERRANDO PIQUERES, JORGE USÓ BLASCO
Published: 3 October 2023
LETTER TO THE EDITOR
http://www.doi.org/10.37201/req/069.2023
Rev Esp Quimioter 2023; 36(6): 655-657 [Full-text PDF]
